Neil Woodford's top ten holdings in his Woodford Equity Income fund contain few surprises, with AstraZeneca, GlaxoSmithKline and British American Tobacco the three largest positions.
Neville White, socially responsible investment analyst at Ecclesiastical Investment Management, explains what investors should take away from recent high profile corporate governance scandals.
Multi-managers reveal the funds that helped them navigate their portfolios through a difficult 2011.
Low valuations and leaner companies mean now is a good time to increase equity holdings.